- Home
- AXS vs STVN Comparison
AXS vs STVN Comparison
Compare AXS & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXS
- STVN
- Stock Information
- Founded
- AXS 2001
- STVN 1949
- Country
- AXS Bermuda
- STVN Italy
- Employees
- AXS N/A
- STVN N/A
- Industry
- AXS Property-Casualty Insurers
- STVN Containers/Packaging
- Sector
- AXS Finance
- STVN Consumer Discretionary
- Exchange
- AXS Nasdaq
- STVN Nasdaq
- Market Cap
- AXS 7.6B
- STVN 6.2B
- IPO Year
- AXS N/A
- STVN 2021
- Fundamental
- Price
- AXS $90.06
- STVN $20.64
- Analyst Decision
- AXS Strong Buy
- STVN Buy
- Analyst Count
- AXS 7
- STVN 6
- Target Price
- AXS $98.71
- STVN $27.50
- AVG Volume (30 Days)
- AXS 658.9K
- STVN 400.0K
- Earning Date
- AXS 01-29-2025
- STVN 11-05-2024
- Dividend Yield
- AXS 1.96%
- STVN 0.28%
- EPS Growth
- AXS 15.01
- STVN N/A
- EPS
- AXS 7.19
- STVN 0.48
- Revenue
- AXS $5,967,185,000.00
- STVN $1,220,254,294.00
- Revenue This Year
- AXS N/A
- STVN $3.01
- Revenue Next Year
- AXS $7.16
- STVN $7.16
- P/E Ratio
- AXS $12.52
- STVN $43.28
- Revenue Growth
- AXS 6.37
- STVN 3.53
- 52 Week Low
- AXS $53.88
- STVN $16.56
- 52 Week High
- AXS $94.89
- STVN $34.73
- Technical
- Relative Strength Index (RSI)
- AXS 52.37
- STVN 47.10
- Support Level
- AXS $88.34
- STVN $19.25
- Resistance Level
- AXS $94.89
- STVN $23.95
- Average True Range (ATR)
- AXS 2.30
- STVN 1.09
- MACD
- AXS -0.71
- STVN -0.01
- Stochastic Oscillator
- AXS 41.60
- STVN 24.60
About AXS Axis Capital Holdings Limited
Axis Capital Holdings Ltd is a property and casualty insurance company that provides various products and services to clients and distribution partners. The company has operating subsidiaries and branch networks based in Bermuda, the United States, Canada, Europe, and Singapore. Its business consists of two distinct global underwriting platforms, AXIS Insurance, and AXIS Reinsurance. The company manages its portfolio holistically, aiming to construct an optimum consolidated portfolio of funded and unfunded risks.
About STVN Stevanato Group S.p.A.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.